Protect Your Trading Account With Options!

From Tradewins | Ad

This might be the opposite of what you’ve heard, but the real risk in the market now lies with stock trading… “Options Trading Made Easy” by expert Chuck Hughes will show you how the nature of options trading gives you the chance to profit no matter which way the market trends!

Get the e-book today!

>>>

GALT Insider Trading (Galectin Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 39.40%

Insider Buying (Last 12 Months): $91,270.00

Insider Selling (Last 12 Months): $274,500.00

Galectin Therapeutics Insider Trading History Chart

Galectin Therapeutics Share Price & Price History

^$1.31

+0.30 (1.20%)

As of 07/1/2022 01:00 AM ET

Days: 30 | 90 | 365

Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

Galectin Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/19/2022	Kevin D. Freeman	Director	Buy	5,000	$1.33	$6,650.00	65,000
4/18/2022	Kevin D. Freeman	Director	Buy	5,000	$1.71	$8,550.00	60,000
4/4/2022	Richard A. Zordani, Jr.	Director	Buy	5,000	$1.60	$8,000.00	24,583
2/2/2022	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.10	$21,000.00
1/21/2022	Elissa J. Schwartz	Director	Buy	1,000	$2.00	$2,000.00
1/19/2022	Kevin D. Freeman	Director	Buy	5,000	$1.96	$9,800.00
1/14/2022	Richard A. Zordani, Jr.	Director	Buy	5,000	$2.02	$10,100.00
1/11/2022	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.10	$21,000.00
12/6/2021	Kevin D. Freeman	Director	Buy	5,000	$2.34	$11,700.00
12/2/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.37	$23,700.00
11/1/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.19	$31,900.00
10/29/2021	Kevin D. Freeman	Director	Buy	2,000	$3.17	$6,340.00
10/21/2021	Kevin D. Freeman	Director	Buy	2,000	$3.19	$6,380.00
10/19/2021	Kevin D. Freeman	Director	Buy	3,000	$3.37	$10,110.00
10/15/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.37	$33,700.00
10/4/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.62	$36,200.00
9/23/2021	Kevin D. Freeman	Director	Buy	3,000	$3.88	$11,640.00
9/1/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.91	$39,100.00
8/2/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.25	$32,500.00
7/9/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$3.54	$35,400.00
5/3/2021	Fund L.P. 10X	Major Shareholder	Sell	27,500	$3.97	$109,175.00
4/5/2021	Kevin D. Freeman	Director	Buy	5,000	$2.04	$10,200.00	23,469
4/1/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.16	$21,600.00
2/2/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.04	$20,400.00
1/11/2021	Gilbert F Amelio	Director	Sell	60,000	$2.17	$130,200.00	60,614
10/13/2020	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.97	$29,700.00
9/4/2020	Kevin D. Freeman	Director	Buy	5,000	$2.57	$12,850.00	23,469
3/19/2020	Kevin D. Freeman	Director	Buy	6,000	$1.69	$10,140.00
1/17/2020	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.97	$29,700.00
11/15/2019	Kevin D. Freeman	Director	Buy	3,000	$3.36	$10,080.00	23,469
10/10/2019	Fund L.P. 10X	Major Shareholder	Sell	17,000	$3.73	$63,410.00
9/6/2019	Kevin D. Freeman	Director	Buy	1,290	$3.71	$4,785.90	23,469

Being A Successful Trader Just Got Easier…

From Tradewins | Ad

From 10x Trading Champion Chuck Hughes comes the e-book helping thousands to survive the bear market, “Options trading Made Easy”!

Already full of tools and strategies for success, each copy now comes with a daily Trade of the Day, straight from Chuck to you!

Download your copy now!

>>>

SEC Filings (Institutional Ownership Changes) for Galectin Therapeutics (NASDAQ:GALT)

12.35% of Galectin Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Galectin Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2022	State Street Corp	173,740	$0.28M	0.0%	+9.4%	0.293%
5/16/2022	Atria Wealth Solutions Inc.	285,700	$0.46M	0.0%	N/A	0.481%
5/13/2022	Centaurus Financial Inc.	21,114	$34K	0.0%	N/A	0.036%
5/13/2022	Renaissance Technologies LLC	202,018	$0.33M	0.0%	-6.2%	0.340%
5/13/2022	Vanguard Group Inc.	1,940,807	$3.13M	0.0%	-0.5%	3.271%
5/12/2022	PNC Financial Services Group Inc.	56,184	$90K	0.0%	+21.7%	0.095%
5/12/2022	Cambridge Investment Research Advisors Inc.	145,207	$0.23M	0.0%	-5.1%	0.245%
5/4/2022	Advisor Group Holdings Inc.	1,265,820	$2.04M	0.0%	+1.5%	2.133%
5/4/2022	Commonwealth Equity Services LLC	26,902	$43K	0.0%	+59.2%	0.045%
5/3/2022	Cutter & CO Brokerage Inc.	169,578	$0.27M	0.1%	-7.6%	0.286%
2/9/2022	Geneos Wealth Management Inc.	480,767	$1M	0.0%	-2.2%	0.810%
2/7/2022	Benjamin F. Edwards & Company Inc.	29,615	$61K	0.0%	+25.5%	0.050%
2/7/2022	Ameritas Advisory Services LLC	44,232	$92K	0.0%	N/A	0.075%
2/3/2022	Cambridge Investment Research Advisors Inc.	153,027	$0.32M	0.0%	-7.0%	0.258%
2/3/2022	Advisor Group Holdings Inc.	1,247,401	$2.58M	0.0%	-2.1%	2.102%
11/16/2021	Squarepoint Ops LLC	39,191	$0.15M	0.0%	-30.2%	0.066%
11/15/2021	Capstone Investment Advisors LLC	42,260	$0.16M	0.0%	N/A	0.071%
11/12/2021	Ameritas Investment Company LLC	44,232	$0.17M	0.0%	+12.7%	0.075%
11/12/2021	Centaurus Financial Inc.	22,614	$88K	0.0%	+44.8%	0.038%
11/12/2021	Geode Capital Management LLC	540,866	$2.10M	0.0%	+32.2%	0.912%
11/10/2021	Buckingham Strategic Wealth LLC	10,734	$42K	0.0%	N/A	0.018%
11/9/2021	BlackRock Inc.	787,582	$3.06M	0.0%	-0.8%	1.328%
11/8/2021	Keybank National Association OH	100,000	$0.39M	0.0%	N/A	0.169%
11/4/2021	QCI Asset Management Inc. NY	55,000	$0.21M	0.0%	+120.0%	0.093%
11/2/2021	Raymond James & Associates	13,096	$51K	0.0%	N/A	0.022%
11/2/2021	Benjamin F. Edwards & Company Inc.	23,600	$92K	0.0%	-32.0%	0.040%
11/2/2021	Cambridge Investment Research Advisors Inc.	164,498	$0.64M	0.0%	-2.3%	0.277%
10/29/2021	Commonwealth Equity Services LLC	11,902	$46K	0.0%	N/A	0.020%
10/8/2021	Wedbush Securities Inc.	30,998	$0.12M	0.0%	+72.2%	0.052%
9/3/2021	Parametric Portfolio Associates LLC	56,047	$0.18M	0.0%	+62.9%	0.096%
8/25/2021	Marshall Wace LLP	47,509	$0.15M	0.0%	N/A	0.082%
8/17/2021	Millennium Management LLC	568,690	$1.82M	0.0%	N/A	0.979%
8/17/2021	Boothbay Fund Management LLC	10,965	$35K	0.0%	N/A	0.019%
8/16/2021	Squarepoint Ops LLC	56,128	$0.18M	0.0%	N/A	0.097%
8/16/2021	Ameritas Investment Company LLC	39,232	$0.13M	0.0%	N/A	0.068%
8/16/2021	LMR Partners LLP	19,285	$62K	0.0%	N/A	0.033%
8/16/2021	Charles Schwab Investment Management Inc.	17,413	$56K	0.0%	-77.5%	0.030%
8/16/2021	State Street Corp	158,759	$0.51M	0.0%	-74.2%	0.273%
8/16/2021	Tibra Equities Europe Ltd	98,700	$0.32M	0.1%	N/A	0.170%
8/16/2021	Marshall Wace LLP	47,509	$0.15M	0.0%	N/A	0.082%
8/13/2021	Renaissance Technologies LLC	370,199	$1.19M	0.0%	+20.6%	0.637%
8/13/2021	Northern Trust Corp	96,270	$0.31M	0.0%	-77.1%	0.166%
8/13/2021	LPL Financial LLC	52,034	$0.17M	0.0%	+219.5%	0.090%
8/13/2021	Geode Capital Management LLC	409,013	$1.31M	0.0%	-36.7%	0.704%
8/13/2021	Vanguard Group Inc.	1,953,419	$6.25M	0.0%	+1.1%	3.362%
8/12/2021	XTX Topco Ltd	12,419	$40K	0.0%	N/A	0.021%
8/12/2021	Ergoteles LLC	139,181	$0.45M	0.0%	N/A	0.240%
8/11/2021	Bank of New York Mellon Corp	23,080	$74K	0.0%	-76.9%	0.040%
8/11/2021	BlackRock Inc.	793,934	$2.54M	0.0%	-69.7%	1.367%
8/11/2021	Susquehanna Fundamental Investments LLC	15,600	$50K	0.0%	N/A	0.027%
8/10/2021	Cambridge Investment Research Advisors Inc.	168,316	$0.54M	0.0%	N/A	0.290%
8/10/2021	Rockefeller Capital Management L.P.	10,386	$33K	0.0%	+419.3%	0.018%
8/2/2021	Advisor Group Holdings Inc.	1,273,157	$4.07M	0.0%	+4.2%	2.192%
6/17/2021	Geneos Wealth Management Inc.	511,606	$2.26M	0.1%	+5.4%	0.881%
5/19/2021	Virtu Financial LLC	14,683	$32K	0.0%	N/A	0.026%
5/18/2021	D. E. Shaw & Co. Inc.	45,775	$99K	0.0%	-10.8%	0.080%
5/17/2021	Vivaldi Capital Management LLC	10,668	$45K	0.0%	-30.9%	0.019%
5/17/2021	Nuveen Asset Management LLC	177,035	$0.38M	0.0%	-4.2%	0.310%
5/14/2021	Occudo Quantitative Strategies LP	18,967	$41K	0.0%	N/A	0.033%
5/14/2021	Dimensional Fund Advisors LP	11,977	$26K	0.0%	N/A	0.021%
5/13/2021	Barclays PLC	31,094	$68K	0.0%	+159.0%	0.054%
5/13/2021	Renaissance Technologies LLC	307,000	$0.67M	0.0%	+1,864.5%	0.537%
5/13/2021	Neuberger Berman Group LLC	13,614	$30K	0.0%	-25.2%	0.024%
5/13/2021	Bank of New York Mellon Corp	99,901	$0.22M	0.0%	-7.0%	0.175%
5/13/2021	Bank of Montreal Can	21,329	$53K	0.0%	+272.7%	0.037%
5/12/2021	Northern Trust Corp	421,103	$0.91M	0.0%	-7.0%	0.737%
5/12/2021	Geode Capital Management LLC	645,867	$1.40M	0.0%	+0.6%	1.130%
5/12/2021	JPMorgan Chase & Co.	100,555	$0.22M	0.0%	-3.0%	0.176%
5/7/2021	BlackRock Inc.	2,620,626	$5.69M	0.0%	+0.9%	4.585%
5/7/2021	D.A. Davidson & CO.	65,310	$0.14M	0.0%	-91.5%	0.114%
4/26/2021	Wedbush Securities Inc.	17,998	$39K	0.0%	-12.2%	0.031%
3/2/2021	FormulaFolio Investments LLC	12,710	$28K	0.0%	N/A	0.022%
2/19/2021	JPMorgan Chase & Co.	103,713	$0.23M	0.0%	+378.5%	0.182%
2/12/2021	Raymond James Financial Services Advisors Inc.	18,229	$41K	0.0%	N/A	0.032%
2/11/2021	Northern Trust Corp	452,957	$1.01M	0.0%	-2.8%	0.794%
2/11/2021	Barclays PLC	12,006	$27K	0.0%	-30.5%	0.021%
2/10/2021	Renaissance Technologies LLC	15,627	$35K	0.0%	N/A	0.027%
2/10/2021	D.A. Davidson & CO.	767,321	$1.72M	0.0%	-10.1%	1.344%
2/9/2021	Wells Fargo & Company MN	96,815	$0.22M	0.0%	+69.1%	0.170%
2/5/2021	BlackRock Inc.	2,598,089	$5.82M	0.0%	+3.8%	4.552%
2/4/2021	Cambridge Investment Research Advisors Inc.	179,556	$0.40M	0.0%	-6.1%	0.315%
11/13/2020	Morgan Stanley	31,579	$85K	0.0%	-51.6%	0.055%
11/12/2020	JPMorgan Chase & Co.	21,674	$72K	0.0%	-22.6%	0.038%
11/10/2020	State Street Corp	698,113	$1.86M	0.0%	+1.5%	1.223%
11/9/2020	The Manufacturers Life Insurance Company	26,819	$72K	0.0%	+23.4%	0.047%
11/9/2020	LPL Financial LLC	18,584	$50K	0.0%	-34.2%	0.033%
11/6/2020	BlackRock Inc.	2,503,111	$6.68M	0.0%	-0.4%	4.385%
10/29/2020	Cambridge Investment Research Advisors Inc.	191,195	$0.51M	0.0%	-5.8%	0.335%
10/13/2020	Brookstone Capital Management	12,710	$34K	0.0%	N/A	0.022%
9/15/2020	Two Sigma Advisers LP	11,800	$36K	0.0%	N/A	0.021%
8/25/2020	Nuveen Asset Management LLC	181,943	$0.56M	0.0%	+39.9%	0.319%
8/14/2020	Bank of America Corp DE	10,895	$33K	0.0%	+145.8%	0.019%
8/14/2020	Advisor Group Holdings Inc.	1,012,430	$3.10M	0.0%	+17.1%	1.775%
8/13/2020	Vivaldi Capital Management LLC	15,439	$40K	0.0%	+44.7%	0.027%
8/12/2020	Goldman Sachs Group Inc.	20,794	$64K	0.0%	+24.7%	0.036%
7/31/2020	UBS Group AG	12,401	$38K	0.0%	-50.4%	0.022%
6/19/2020	State Street Corp	663,783	$1.30M	0.0%	-1.1%	1.164%
5/18/2020	Advisor Group Holdings Inc.	864,275	$1.69M	0.0%	N/A	1.515%
5/15/2020	Morgan Stanley	55,511	$0.11M	0.0%	-66.1%	0.097%
5/15/2020	Two Sigma Investments LP	16,932	$33K	0.0%	N/A	0.030%

Data available starting January 2016

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

Today's Range

Now: $1.31

$1.28

$1.35

50 Day Range

MA: $1.37

$1.19

$1.68

52 Week Range

Now: $1.31

$1.19

$4.40

Volume

65,895 shs

Average Volume

106,443 shs

Market Capitalization

$77.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.66

Who are the company insiders with the largest holdings of Galectin Therapeutics?: Galectin Therapeutics' top insider investors include:
Kevin D Freeman (Director)
Gilbert F Amelio (Director)
Richard A Jr Zordani (Director)
Elissa J Schwartz (Director)
Fund LP 10X (Major Shareholder)
Learn More about top insider investors at Galectin Therapeutics.